Pan-Immune-Inflammation Value as a Novel Predictor of Contrast-Associated Acute Kidney Injury in Patients Treated

Gökhan Çiçek1, Sadık Kadri Açıkgöz1, Eser Açıkgöz2

  • 1Department of Cardiology, Ankara Bilkent City Hospital, University of Health Sciences, 06800 Ankara, Türkiye.

Insights

The Pan-Immune-Inflammation Value (PIV) can predict contrast-associated acute kidney injury (CA-AKI) in ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). Elevated PIV levels indicate a higher risk of developing CA-AKI after urgent PCI.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarkers

Background:

  • Contrast-associated acute kidney injury (CA-AKI) is a significant complication following procedures requiring intravascular contrast agents.
  • Early identification of patients at high risk for CA-AKI is crucial, particularly for ST-segment elevation myocardial infarction (STEMI) patients undergoing urgent percutaneous coronary intervention (PCI).

Purpose of the Study:

  • To evaluate the prognostic value of the Pan-Immune-Inflammation Value (PIV) in predicting CA-AKI.
  • To assess PIV as a biomarker in STEMI patients undergoing urgent PCI.

Main Methods:

  • Retrospective study of 2325 STEMI patients who underwent urgent PCI within 12 hours of symptom onset.
  • CA-AKI defined as a >25% or ≥0.5 mg/dL increase in serum creatinine within 48-72 hours post-procedure.
  • Analysis of admission PIV levels and their correlation with CA-AKI development using ROC and multivariate logistic regression.

Main Results:

  • Patients who developed CA-AKI had significantly higher PIV levels (502.5 ± 324.5 vs. 264.7 ± 165.8; p < 0.001).
  • A PIV cutoff value >320 demonstrated an AUC of 0.753 (95% CI: 0.740-0.787; p < 0.001), with 67% sensitivity and 66.9% specificity.
  • Elevated PIV (>320) was an independent predictor of CA-AKI (OR 2.118; 95% CI: 1.329-3.790; p < 0.001), along with age, Killip class, and contrast volume.

Conclusions:

  • Elevated admission PIV is a practical and independent biomarker for predicting CA-AKI in STEMI patients undergoing PCI.
  • PIV offers a valuable tool for risk stratification and potential early intervention in this high-risk patient population.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
482
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.5K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.9K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.2K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
421
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.6K